PedAM
Pediatric Disease Annotations & Medicines
| Disease | heart disease |
| Symptom | C0039231|tachycardia |
| Sentences | 37 |
| PubMedID- 26134577 | Role of cardiac magnetic resonance imaging in the management and treatment of ventricular tachycardia in patients with structural heart disease. |
| PubMedID- 23483757 | We defined “benign palpitation” as sinus tachycardia without any evidence of structural heart disease or systemic causes. |
| PubMedID- 21419424 | The purpose of the study was to evaluate the long-term prognosis of ventricular tachycardia (vt) in patients without structural heart disease (hd). |
| PubMedID- 22851674 | Such arrhythmias account for ∼70% of the cases of ventricular tachycardia in patients without structural heart disease (lerman et al., 1986). |
| PubMedID- 21271170 | Objective: to evaluate whether the epicardial mapping with multiple electrodes carried out simultaneously with the endocardial mapping helps in ablation procedures of sustained ventricular tachycardia (vt) in patients with nonischemic heart disease. |
| PubMedID- 26336519 | Long-term outcomes of catheter ablation of ventricular tachycardia in patients with structural heart disease. |
| PubMedID- 21119512 | The role of catheter ablation for ventricular tachycardia in patients with ischemic heart disease. |
| PubMedID- 20544616 | Structural heart disease and other causes of tachycardia were discarded. |
| PubMedID- 21808398 | Heart rate is an important determinant of myocardial oxygen demand, and tachycardia in patients with ischaemic heart disease is a risk factor for the development of perioperative myocardial ischaemia and infarction. |
| PubMedID- 24942403 | Aims: to assess the efficacy of non-contact mapping for outflow tract premature ventricular contraction (pvc) and ventricular tachycardia (vt) ablation in patients without structural heart disease and a precordial transition at v3 or later and to determine the diagnostic accuracy of new virtual unipolar electrogram criteria for distinguishing left from right-sided foci using a multi-electrode array positioned within the right ventricular outflow tract. |
| PubMedID- 20450299 | Ventricular tachycardia (vt) in patients without structural heart disease can be observed in 10% of patients presenting with ventricular arrhythmias. |
| PubMedID- 24351028 | Conclusions: landiolol for ctca diagnosis in patients suspected of coronary heart disease with tachycardia is thought to be cost saving. |
| PubMedID- 23626436 | 2 atrial pacing may also help prevent paroxysmal supraventricular tachycardia in certain forms of congenital heart disease, but definitive proof for this effect is lacking. |
| PubMedID- 22199146 | Aims: the purpose of the study was to evaluate the role of coronary venous mapping to identify epicardial ventricular tachycardia (vt) in patients with structural heart disease. |
| PubMedID- 26056239 | Endo-epicardial versus only-endocardial ablation as a first line strategy for the treatment of ventricular tachycardia in patients with ischemic heart disease. |
| PubMedID- 21816308 | Background: early repolarization has been implicated in a syndrome of polymorphic ventricular tachycardia and fibrillation in patients without organic heart disease. |
| PubMedID- 24670834 | Catheter ablation is a well-established therapeutic option for management of recurrent ventricular tachycardia in patients with ischemic/non-ischemic heart disease and procedural complications include a mortality rate of up to 3% and a risk of major complications up to 10%. |
| PubMedID- 25488957 | Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome. |
| PubMedID- 23131194 | Introduction: descriptions for left atrial macroreentry tachycardia (lamrt) in patients without obvious structural heart disease or previous surgery or catheter radiofrequency (rf) ablation have been sparse. |
| PubMedID- 21147263 | Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. |
| PubMedID- 21848635 | Background: reentrant ventricular outflow tract (ot) tachycardia is rare in patients with nonischemic heart disease. |
| PubMedID- 20723092 | Objective: to evaluate acute and long-term efficiency of the newly available irrigated tip magnetic catheter for radiofrequency (rf) ablation of scar-related ventricular tachycardia (vt) in patients with ischemic heart disease. |
| PubMedID- 25016150 | Background: there is a paucity of data regarding the complications and in-hospital mortality after catheter ablation for ventricular tachycardia (vt) in patients with ischemic heart disease. |
| PubMedID- 22460166 | Background: invasive and non-invasive tests have been used to identify the risk of ventricular tachycardia (vt) in patients with chronic chagas' heart disease (cchd). |
| PubMedID- 21556158 | We have previously reported the ability of ranolazine to favorable effect ventricular ectopy in a case on non-ischemic cardiomyopathy in a rapid manner as well idiopathic ventricular tachycardia in a patient without structural heart disease . |
| PubMedID- 20433682 | Management of ventricular tachycardia in patients with structural heart disease. |
| PubMedID- 23727700 | Acute failure of catheter ablation for ventricular tachycardia due to structural heart disease: causes and significance. |
| PubMedID- 22452674 | Can we eliminate noninducibility by programmed stimulation as an endpoint for ventricular tachycardia ablation in patients with structural heart disease. |
| PubMedID- 25136076 | Correlates and prognosis of early recurrence after catheter ablation for ventricular tachycardia due to structural heart disease. |
| PubMedID- 23015920 | Any ventricular tachycardia in the presence of structural heart disease, regardless of ablation or other suppressive therapies, is reason for exclusion from all sports except class 1a. |
| PubMedID- 22125669 | Role of catheter ablation of ventricular tachycardia associated with structural heart disease. |
| PubMedID- 24460505 | Objectives: we conducted a study to assess the acute procedural success and the long-term effect of radiofrequency ablation (rfa) for ventricular tachycardia (vt) in patients with ischaemic heart disease. |
| PubMedID- 24536081 | Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%. |
| PubMedID- 20946289 | Methods and results: we retrospectively evaluated the ventricular tachycardia (vt) rates in patients with structural heart disease actively treated with therapies with antifibrotic properties. |
| PubMedID- 24486263 | Ablation of the epicardial substrate in ventricular tachycardia associated with structural heart disease: outside in or inside out. |
| PubMedID- 20811538 | While often associated with a primary cardiomyopathy, they have also been known to cause tachycardia-induced cardiomyopathy in patients without preceding structural heart disease. |
| PubMedID- 23508287 | Polymorphic ventricular tachycardia (vt) in patients with no heart disease can be attributable to catecholamine sensitive polymorphic vt, short coupled variant of torsade de pointes, or idiopathic ventricular fibrillation (vf). |
Page: 1